Table 6.
The results obtained from docking of Drugs with 6M0J in site 2.
Drugs | S score (kcal/mol) | RMSD (Å) | Bonds
between atoms of compounds and residues of active site 2 of 6M0J |
|||||
---|---|---|---|---|---|---|---|---|
Atom of compound | Atom of receptor | Involved receptor residues | Type of interaction bond | Distance (Å) | E (kcal/mol) | |||
Chloroquine | −5.4920 | 2.3627 | C-45 | 5-ring | His 401 | H-pi | 4.25 | −0.9 |
Delapril | -8.1604 | 1.5603 | O-26 | ZN | Zn 901 | metallic | 2.13 | −3.6 |
Zn-901 | NE2 | His 374 | 2.4 | −3.2 | ||||
His 378 | 2.27 | −5.7 | ||||||
OE1 | Glu 402 | 2.1 | −5.6 | |||||
NE2 | His 378 | ionic | 2.27 | −11.7 | ||||
OE1 | Glu 402 | 2.1 | −14.4 | |||||
OE2 | Glu 402 | 3.13 | −3.7 | |||||
Enalapril | −6.7570 | 2.6763 | O-14 | ZN | Zn 901 | metallic | 2 | −2.5 |
Zn-901 | NE2 | His 374 | 2.4 | −3.2 | ||||
NE2 | His 378 | 2.27 | −5.7 | |||||
OE1 | Glu 402 | 2.1 | −5.6 | |||||
NE2 | His 378 | ionic | 2.27 | −11.7 | ||||
OE1 | Glu 402 | 2.1 | −14.4 | |||||
OE2 | Glu 402 | 3.13 | −3.7 | |||||
C-52 | 5-ring | His 378 | H-pi | 3.88 | −1 | |||
Hydroxychloroquine | −6.3125 | 1.8513 | O-2 | OE2 | Glu 375 | H-donor | 2.86 | −1.9 |
O-2 | ZN | Zn 901 | metallic | 2 | −2.6 | |||
Zn-901 | NE2 | His 374 | 2.4 | −3.2 | ||||
NE2 | His 378 | 2.27 | −5.7 | |||||
OE1 | Glu 402 | 2.1 | −5.6 | |||||
NE2 | His 378 | ionic | 2.27 | −11.7 | ||||
OE1 | Glu 402 | 2.1 | −14.4 | |||||
OE2 | Glu 402 | 3.13 | −3.7 | |||||
C-47 | 5-ring | His 378 | H-pi | 4.12 | −0.6 | |||
Lisinopril | −6.6966 | 1.9981 | O-5 | O | H2O 1004 | H-donor | 2.97 | −2 |
O-1 | ZN | Zn 901 | metallic | 2.06 | −2.3 | |||
Zn-901 | NE2 | His 374 | 2.4 | −3.2 | ||||
NE2 | His 378 | 2.27 | −5.7 | |||||
OE1 | Glu 402 | 2.1 | −5.6 | |||||
NE2 | His 378 | ionic | 2.27 | −11.7 | ||||
OE1 | Glu 402 | 2.1 | −14.4 | |||||
OE2 | Glu 402 | 3.13 | −3.7 | |||||
6-ring | N | Ile 291 | pi-H | 3.98 | −1.1 | |||
ORE-1001 | −6.2755 | 2.5319 | N-6 | OH | Tyr 515 | H-acceptor | 3.09 | −2.1 |
O-25 | ZN | Zn 901 | metallic | 2.09 | −2.3 | |||
O-31 | ZN | Zn 901 | 2.31 | −0.9 | ||||
Zn-901 | NE2 | His 374 | 2.4 | −3.2 | ||||
NE2 | His 378 | 2.27 | −5.7 | |||||
OE1 | Glu 402 | 2.1 | −5.6 | |||||
NE2 | His 378 | ionic | 2.27 | −11.7 | ||||
OE1 | Glu 402 | 2.1 | −14.4 | |||||
OE2 | Glu 402 | 3.13 | −3.7 | |||||
Perindopril | −6.7968 | 2.2965 | O-23 | O | Glu 398 | H-donor | 2.84 | −3.1 |
N-26 | OE1 | Glu 402 | 3.11 | −1.4 | ||||
C-46 | OE2 | Glu 375 | 3.49 | −0.6 | ||||
O-16 | O | H2O 1033 | H-acceptor | 2.86 | −1.9 | |||
O-25 | NH2 | Arg 514 | 2.91 | −1.9 | ||||
O-42 | ZN | Zn 901 | metallic | 1.97 | −2.9 | |||
Zn-901 | NE2 | His 374 | 2.4 | −3.2 | ||||
NE2 | His 378 | 2.27 | −5.7 | |||||
OE1 | Glu 402 | 2.1 | −5.6 | |||||
NE2 | His 378 | ionic | 2.27 | −11.7 | ||||
OE1 | Glu 402 | 2.1 | −14.4 | |||||
OE2 | Glu 402 | 3.13 | −3.7 | |||||
Ramipril | −7.6305 | 2.4853 | O-53 | ZN | Zn 901 | metallic | 2.13 | −1.7 |
O-58 | ZN | Zn 901 | 2.44 | −1.4 | ||||
Zn-901 | NE2 | His 374 | 2.4 | −3.2 | ||||
NE2 | His 378 | 2.27 | −5.7 | |||||
OE1 | Glu 402 | 2.1 | −5.6 | |||||
NE2 | His 378 | ionic | 2.27 | −11.7 | ||||
OE1 | Glu 402 | 2.1 | −14.4 | |||||
OE2 | Glu 402 | 3.13 | −3.7 | |||||
Ramiprilat | −7.1864 | 1.7252 | O-45 | Zn | Zn 901 | metallic | 1.94 | −2.9 |
Zn-901 | NE2 | His 374 | 2.4 | −3.2 | ||||
NE2 | His 378 | 2.27 | −5.7 | |||||
OE1 | Glu 402 | 2.1 | −5.6 | |||||
NE2 | His 378 | ionic | 2.27 | −11.7 | ||||
OE1 | Glu 402 | 2.1 | −14.4 | |||||
OE2 | Glu 402 | 3.13 | −3.7 | |||||
Trandolapril | −7.1160 | 1.9818 | O-1 | O | H2O 1030 | H-acceptor | 3.04 | −1 |
O-4 | ZN | Zn 901 | metallic | 2.07 | −3.8 | |||
Zn-901 | NE2 | His 374 | 2.4 | −3.2 | ||||
NE2 | His 378 | 2.27 | −5.7 | |||||
OE1 | Glu 402 | 2.1 | −5.6 | |||||
NE2 | His 378 | ionic | 2.27 | −11.7 | ||||
OE1 | Glu 402 | 2.1 | −14.4 | |||||
OE2 | Glu 402 | 3.13 | −3.7 | |||||
6-ring | CA | Glu 398 | pi-H | 3.63 | −0.6 |